Role of Pretreatment Hemoglobin-to-Platelet Ratio in Predicting Survival Outcome of Locally Advanced Nasopharyngeal Carcinoma Patients

Figure 1

Receiver operating characteristic curve for HPR to three-year mortality (AUC 0.6228, 95% CI: 0.56-0.69).